Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiotherapy, Image-Guided”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00490282
What this trial is testing

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharyngeal Cancer
M.D. Anderson Cancer Center 25
Not applicableStudy completedNCT04134975
What this trial is testing

Evaluation of the Contribution of Intraoperative Scans Coupled With the Navigation for the Precision of the Positioning of the Pedicle Screws During a Lumbar Spine Surgery: a Prospective Randomised Study

Who this might be right for
Lumbar Disc DiseaseSurgical Procedure, Unspecified
GCS Ramsay Santé pour l'Enseignement et la Recherche 126
Not applicableUnknownNCT03411408
What this trial is testing

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.

Who this might be right for
Malignant GliomaHigh Grade GliomaRecurrent Glioma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 24
Testing effectiveness (Phase 2)Ended earlyNCT03522584
What this trial is testing

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University of Washington 6
Not applicableLooking for participantsNCT06306170
What this trial is testing

Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Who this might be right for
Gynecologic CancerRadiotherapy Side EffectRadiotherapy; Complications+3 more
IRCCS San Raffaele 1,000
Not applicableLooking for participantsNCT04831983
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Who this might be right for
Prostate Cancer
University of Milano Bicocca 30
Not applicableStudy completedNCT05746156
What this trial is testing

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

Who this might be right for
Locally Advanced Cervical Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 17
Not applicableStudy completedNCT03376386
What this trial is testing

Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy

Who this might be right for
Head and Neck Cancer
The Netherlands Cancer Institute 20
Not applicableUnknownNCT03727698
What this trial is testing

Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment

Who this might be right for
Cancer
Institute of Cancer Research, United Kingdom 200
Early research (Phase 1)Study completedNCT04870840
What this trial is testing

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell Carcinoma+16 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT02388308
What this trial is testing

Evaluation of Clarity Ultrasound Guidance for Prostate Therapy

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 61
Large-scale testing (Phase 3)Active Not RecruitingNCT01223248
What this trial is testing

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Who this might be right for
MelanomaOvarian CancerSarcoma+4 more
Memorial Sloan Kettering Cancer Center 220
Not applicableActive Not RecruitingNCT07605507
What this trial is testing

Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer

Who this might be right for
Cervical Cancer
Siriraj Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00599833
What this trial is testing

Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
The Christie NHS Foundation Trust 44
Post-approval studies (Phase 4)WithdrawnNCT03215355
What this trial is testing

Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer
Slawa Cwajna
Not applicableActive Not RecruitingNCT07272356
What this trial is testing

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

Who this might be right for
Lung Cancer (Non-Small Cell)Lung Metastases From Any Primary
Aurimas Macionis 68
Not applicableStudy completedNCT02272400
What this trial is testing

Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation

Who this might be right for
Breast Cancer
NYU Langone Health 310
Early research (Phase 1)Study completedNCT03253744
What this trial is testing

Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy

Who this might be right for
Prostate CancerProstatic Neoplasm
National Cancer Institute (NCI) 17
Not applicableStudy completedNCT03030625
What this trial is testing

VMAT for Dominant Intraprostatic Lesion

Who this might be right for
Prostate Cancer
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 30
Not applicableNot Yet RecruitingNCT07644754
What this trial is testing

Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer Metastatic to Bone
University Hospital Tuebingen 27
Next Page